Anticoagulation therapy.

J. A. Ginsberg, M. A. Crowther, Richard H White, T. L. Ortel

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Despite refinements and standardization in the use of anticoagulants, many problems remain for clinicians. Dr. Crowther describes appropriate starting and maintenance doses of warfarin, factors accounting for inter- and intra-observer variability and importantly, the management of the over-anticoagulated patients and bleeding patients. Dr. White compares unfractionated heparin (UFH) and low molecular weight heparin (LMWH) and addresses whether there truly are differences in the efficacy and safety of different LMWH's for both arterial and venous indications. Dr. Ortel discusses the management of the problem patient who requires anticoagulants, the management of heparin-induced thrombocytopenia, the pregnant patient, the obese patient, patients who have renal insufficiency and/or liver disease, patients with malignant disease, and other challenging patient populations.

Original languageEnglish (US)
Pages (from-to)339-357
Number of pages19
JournalHematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program
StatePublished - 2001
Externally publishedYes

Fingerprint

Low Molecular Weight Heparin
Therapeutics
Anticoagulants
Heparin
Observer Variation
Warfarin
Thrombocytopenia
Renal Insufficiency
Liver Diseases
Hemorrhage
Safety
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Anticoagulation therapy. / Ginsberg, J. A.; Crowther, M. A.; White, Richard H; Ortel, T. L.

In: Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 2001, p. 339-357.

Research output: Contribution to journalArticle

@article{8e2f5a126db744f2b687069a8a7d7eb2,
title = "Anticoagulation therapy.",
abstract = "Despite refinements and standardization in the use of anticoagulants, many problems remain for clinicians. Dr. Crowther describes appropriate starting and maintenance doses of warfarin, factors accounting for inter- and intra-observer variability and importantly, the management of the over-anticoagulated patients and bleeding patients. Dr. White compares unfractionated heparin (UFH) and low molecular weight heparin (LMWH) and addresses whether there truly are differences in the efficacy and safety of different LMWH's for both arterial and venous indications. Dr. Ortel discusses the management of the problem patient who requires anticoagulants, the management of heparin-induced thrombocytopenia, the pregnant patient, the obese patient, patients who have renal insufficiency and/or liver disease, patients with malignant disease, and other challenging patient populations.",
author = "Ginsberg, {J. A.} and Crowther, {M. A.} and White, {Richard H} and Ortel, {T. L.}",
year = "2001",
language = "English (US)",
pages = "339--357",
journal = "Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program",
issn = "1520-4391",
publisher = "American Society of Hematology",

}

TY - JOUR

T1 - Anticoagulation therapy.

AU - Ginsberg, J. A.

AU - Crowther, M. A.

AU - White, Richard H

AU - Ortel, T. L.

PY - 2001

Y1 - 2001

N2 - Despite refinements and standardization in the use of anticoagulants, many problems remain for clinicians. Dr. Crowther describes appropriate starting and maintenance doses of warfarin, factors accounting for inter- and intra-observer variability and importantly, the management of the over-anticoagulated patients and bleeding patients. Dr. White compares unfractionated heparin (UFH) and low molecular weight heparin (LMWH) and addresses whether there truly are differences in the efficacy and safety of different LMWH's for both arterial and venous indications. Dr. Ortel discusses the management of the problem patient who requires anticoagulants, the management of heparin-induced thrombocytopenia, the pregnant patient, the obese patient, patients who have renal insufficiency and/or liver disease, patients with malignant disease, and other challenging patient populations.

AB - Despite refinements and standardization in the use of anticoagulants, many problems remain for clinicians. Dr. Crowther describes appropriate starting and maintenance doses of warfarin, factors accounting for inter- and intra-observer variability and importantly, the management of the over-anticoagulated patients and bleeding patients. Dr. White compares unfractionated heparin (UFH) and low molecular weight heparin (LMWH) and addresses whether there truly are differences in the efficacy and safety of different LMWH's for both arterial and venous indications. Dr. Ortel discusses the management of the problem patient who requires anticoagulants, the management of heparin-induced thrombocytopenia, the pregnant patient, the obese patient, patients who have renal insufficiency and/or liver disease, patients with malignant disease, and other challenging patient populations.

UR - http://www.scopus.com/inward/record.url?scp=0035225634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035225634&partnerID=8YFLogxK

M3 - Article

C2 - 11722992

AN - SCOPUS:0035225634

SP - 339

EP - 357

JO - Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

JF - Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

SN - 1520-4391

ER -